English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 23, 2025

State Sen. Baldacci: 340B reform ‘could help hospitals alone to the tune of 50 to 70 million per year'
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

American Lung Association's annual report analyzes California air pollution progress
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

New report highlights worsening air quality in the United States
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

New insights into metastatic medulloblastoma offer potential therapeutic strategy
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

Researchers link heart attack severity to time of day
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

PhD student Paulina Horton explores immune system intricacies at UTHealth Houston
+ Pharmaceuticals
Patient Daily | Apr 22, 2025

Patients Come First spokesperson: 'The 340B program’s fatal flaw is a lack of transparency’
+ Pharmaceuticals
Patient Daily | Apr 22, 2025

National Consumers League CEO: 340B program abuse is 'a financial bonanza for non-profit hospitals'

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes